RESUMEN
Background The association between ketogenic diet (KD) and prolonged QT interval, life-threatening ventricular arrhythmias, and sudden death is controversial. Aim We aimed to prospectively evaluate the effect of KD on electrocardiography (ECG) measures in children with refractory epilepsy. Method A total of 70 children with drug-resistant epilepsy who received a KD for at least 12 months were included in the study. The standard 12-lead electrocardiography was performed in all patients before the beginning and in the 12th month of KD. Heart rate, P-wave duration and dispersion, corrected QT interval and QT dispersion, and Tp-e interval were measured. Results All ECG-derived parameters, but P-wave dispersion increased after 12 months of KD compared with the baseline values. However, these changes were not statistically significant. Conclusion A 12-month long 3:1 KD treatment exerts no deleterious effect on cardiac repolarization measures.
Asunto(s)
Arritmias Cardíacas/inducido químicamente , Dieta Cetogénica/efectos adversos , Epilepsia Refractaria/dietoterapia , Adolescente , Errores Innatos del Metabolismo de los Carbohidratos/complicaciones , Niño , Preescolar , Epilepsia Refractaria/etiología , Electrocardiografía , Epilepsias Mioclónicas/dietoterapia , Femenino , Estudios de Seguimiento , Frecuencia Cardíaca , Humanos , Hipoxia-Isquemia Encefálica/complicaciones , Lactante , Síndrome de Landau-Kleffner/complicaciones , Síndrome de Lennox-Gastaut/dietoterapia , Masculino , Malformaciones del Desarrollo Cortical/complicaciones , Proteínas de Transporte de Monosacáridos/deficiencia , Estudios Prospectivos , Espasmos Infantiles/dietoterapia , Estado Epiléptico/dietoterapia , Esclerosis Tuberosa/complicaciones , Adulto JovenRESUMEN
PURPOSE: Long-term ketogenic diet (KD) treatment has been shown to induce liver steatosis and gallstone formation in some in vivo and clinical studies. The aim of this retrospective study was to evaluate the hepatic side effects of KD in epileptic children. METHOD: A total of 141 patients (mean age: 7.1±4.1years [2-18 years], 45.4% girls), receiving KD at least one year for intractable epilepsy due to different diagnoses (congenital brain defects, GLUT-1 deficiency, West syndrome, tuberous sclerosis, hypoxic brain injury, etc.) were included in the study. Serum triglyceride, cholesterol, aminotransferase, bilirubin, protein and albumin levels and abdominal ultrasonography were recorded before and at 1, 3, 6, and 12 months following after diet initiation. RESULTS: The mean duration of KD was 15.9±4.3months. At one month of therapy, three patients had elevated alanine and aspartate aminotransferase levels. These patients were receiving ketogenic diet for Doose syndrome, idiopathic epilepsy and GLUT-1 deficiency. Hepatosteatosis was detected in three patients at 6 months of treatment. Two of these patients were treated with KD for the primary diagnosis of tuberous sclerosis and one for Landau Kleffner syndrome. Cholelithiasis was detected in two patients at 12 months of treatment. They were receiving treatment for West syndrome and hypoxic brain injury sequelae. CONCLUSION: Long-term ketogenic diet treatment stimulates liver parenchymal injury, hepatic steatosis and gallstone formation. Patients should be monitored by screening liver enzymes and abdominal ultrasonography in order to detect these side effects.